Skip to main content
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1997 Dec;119(3):349–356. doi: 10.1017/s0950268897007899

The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan.

S P Luby 1, K Qamruddin 1, A A Shah 1, A Omair 1, O Pahsa 1, A J Khan 1, J B McCormick 1, F Hoodbhouy 1, S Fisher-Hoch 1
PMCID: PMC2809008  PMID: 9440439

Abstract

To determine the prevalence and routes of transmission of hepatitis C virus (HCV) infection in Hafizabad, Pakistan, we collected sera in 1993 from a geographically based random sample of residents, and in 1994 identified 15 HCV-infected individuals (cases) and 67 age and sex matched uninfected individuals (controls). Initially we approached 504 households, and collected serum from a randomly selected household member in 309 (64%). Twenty persons (6.5%) had anti-HCV antibody; 31% percent had hepatitis B core antibodies, and 4.3% had hepatitis B surface antigen. In the case-control study, persons who received more therapeutic injections (categorized as averaging 1, 2-4, 5-9 or > 10 injections per year in the previous 10 years) were more likely to be infected with HCV (odds ratio 0, 1.5, 2.5 and 6.9 respectively, P = 0.008) compared to persons averaging 0 injections per year. Efforts to limit therapeutic injections to only those that are medically indicated and that use sterile equipment are essential in order to prevent transmission of HCV.

Full Text

The Full Text of this article is available as a PDF (178.6 KB).


Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES